The in vivo cardiac kinetics of Tc-99m N-NOET are accelerated in obese, hyperlipidemic Zucker rats

J Nucl Cardiol. 2006 Jan-Feb;13(1):75-82. doi: 10.1016/j.nuclcard.2005.12.002.

Abstract

Background: Previous studies demonstrated that the intrinsic myocardial washout of bis(N-ethoxy,N-ethyldithiocarbamato)nitrido technetium(V) (technetium 99m N-NOET) was affected by changes occurring in the intravascular compartment such as variations in circulating lipid levels. We sought to determine whether the myocardial kinetics of Tc-99m N-NOET were affected by hyperlipidemia in a clinically relevant experimental model.

Methods and results: Tc-99m N-NOET (50 MBq/kg) and thallium 201 (12 MBq/kg) were injected intravenously into hyperlipidemic fa/fa Zucker rats (n=6) and their lean, normolipidemic littermates (n=8), and dual-isotope in vivo planar imaging was performed for 60 minutes. In vivo image quantification indicated significantly faster cardiac washout of Tc-99m N-NOET in fa/fa animals versus lean animals (time constant, 411+/-64 minutes vs 1094+/-226 minutes, respectively; P<.05), whereas Tl-201 cardiac washout was not affected (356+/-85 minutes vs 337+/-53 minutes, respectively; P=not significant).

Conclusion: The cardiac kinetics of Tc-99m N-NOET, but not those of Tl-201, were accelerated after intravenous injection of the tracer in fa/fa Zucker rats with circulating lipid levels similar to those encountered clinically in hyperlipidemic patients. The relationship between lipidemia and the rate of Tc-99m N-NOET myocardial washout warrants further clinical investigation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Heart / diagnostic imaging
  • Hyperlipidemias / complications
  • Hyperlipidemias / diagnostic imaging*
  • Hyperlipidemias / metabolism*
  • Kinetics
  • Metabolic Clearance Rate
  • Myocardium / metabolism*
  • Obesity / complications
  • Obesity / diagnostic imaging*
  • Obesity / metabolism*
  • Organ Specificity
  • Organotechnetium Compounds / pharmacokinetics*
  • Radionuclide Imaging
  • Radiopharmaceuticals / pharmacokinetics
  • Rats
  • Rats, Zucker
  • Thinness / complications
  • Thinness / diagnostic imaging
  • Thinness / metabolism
  • Thiocarbamates / pharmacokinetics*
  • Tissue Distribution

Substances

  • Organotechnetium Compounds
  • Radiopharmaceuticals
  • Thiocarbamates
  • technetium Tc 99m, bis(N-ethoxy-N-ethyldithiocarbamato)nitrido-